1. Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice. (17th November 2021) Authors: Ruggiero, A.; Fabbrocini, G.; Cinelli, E.; Ocampo Garza, S. S.; Camela, E.; Megna, M. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 3(2022) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice. (1st March 2022) Authors: Ruggiero, A.; Fabbrocini, G.; Cinelli, E.; Ocampo Garza, S. S.; Camela, E.; Megna, M. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 3(2022) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Apremilast efficacy and safety in elderly psoriasis patients over a 48‐week period. (28th July 2020) Authors: Megna, M.; Fabbrocini, G.; Camela, E.; Cinelli, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 11(2020) Page Start: e705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case series showing the efficacy of 5‐aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor‐induced paronychia and pyogenic granuloma‐like lesions. (1st March 2019) Authors: Panariello, L.; Donnarumma, M.; Cinelli, E.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 180:Number 3(2019) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Case series showing the efficacy of 5‐aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor‐induced paronychia and pyogenic granuloma‐like lesions. (29th November 2018) Authors: Panariello, L.; Donnarumma, M.; Cinelli, E.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 180:Number 3(2019) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview. (9th December 2021) Authors: Villani, A.; Scalvenzi, M.; Peduto, T.; Cinelli, E.; Fabbrocini, G.; Di Stefani, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period. (19th January 2020) Authors: Megna, M.; Cinelli, E.; Balato, A.; Gallo, L.; Fabbrocini, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 3(2020) Page Start: e152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period. (1st October 2020) Authors: Megna, M.; Camela, E.; Cinelli, E.; Fabbrocini, G. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 7(2020) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period. (2nd June 2020) Authors: Megna, M.; Camela, E.; Cinelli, E.; Fabbrocini, G. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 7(2020) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗